Back to Search
KAREN QUILLEN, M.D.
M.D.
Blood Banking & Transfusion Medicine Physician
NPI: 1750354130IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology (Internal Medicine) Physician
Internal Medicine — Hematology
Code: 207RH0000X
154579(MA)
Blood Banking & Transfusion Medicine PhysicianPrimary
Pathology — Blood Banking & Transfusion Medicine
Code: 207ZB0001X
154579(MA)
Education
OTHER
Class of 1991
Research & Publications (20)
Prevalence of ceftriaxone-induced red blood cell antibodies in pediatric patients with sickle cell disease and human immunodeficiency virus infection.
PMID 18316983·Pediatr Infect Dis J·2008
8-other
Quality improvement to decrease specimen mislabeling in transfusion medicine.
PMID 16879023·Arch Pathol Lab Med·2006
8-other
The determinants of granulocyte yield in 1198 granulocyte concentrates collected from unrelated volunteer donors mobilized with dexamethasone and granulocyte-colony-stimulating factor: a 13-year experience.
PMID 19040597·Transfusion·2009
8-other
Ten-year follow-up of unrelated volunteer granulocyte donors who have received multiple cycles of granulocyte-colony-stimulating factor and dexamethasone.
PMID 19243544·Transfusion·2009
8-other
Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a 'melphalan recall' reaction.
PMID 19421171·Bone Marrow Transplant·2010
8-other
Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease.
PMID 19454500·Haematologica·2009
8-other
Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions.
PMID 19453987·Transfusion·2009
5-case
Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy.
PMID 17381636·Transfusion·2007
8-other
Effect of hydroxyurea on immature reticulocyte fraction in sickle cell anemia.
PMID 17984040·Lab Hematol·2007
8-other
Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem-cell transplantation.
PMID 17673601·Blood·2007
3-trial
Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis.
PMID 17589534·Bone Marrow Transplant·2007
3-trial
Successful treatment of AL amyloidosis with high-dose melphalan and autologous stem cell transplantation in patients over age 65.
PMID 16926284·Blood·2006
3-trial
Clinical and molecular characteristics of patients with non-amyloid light chain deposition disorders, and outcome following treatment with high-dose melphalan and autologous stem cell transplantation.
PMID 16862166·Bone Marrow Transplant·2006
8-other
Predictive factors for hematopoietic engraftment after autologous peripheral blood stem cell transplantation for AL amyloidosis.
PMID 15665842·Bone Marrow Transplant·2005
8-other
Pericardial effusion: a rare presentation of adult T-cell leukemia/lymphoma.
PMID 15551279·Am J Hematol·2004
5-case
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation.
PMID 15155460·Blood·2004
3-trial
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study.
PMID 14734330·Ann Intern Med·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 133 BROOKLINE AVE
BOSTON, MA 02215 - Phone
- (671) 421-5950
Quick Facts
- NPI
- 1750354130
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile